Join and network with over 350 industry leaders at Discovery US 2024, where we will address the latest advancements in target identification, validation and HIT optimisation.
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.
The 2024 event again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
Below were some of the confirmed speakers for the Discovery US 2023 event
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of on-site experiences.